TEDESCHI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 4.455
AS - Asia 4.318
EU - Europa 3.704
SA - Sud America 308
AF - Africa 236
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.038
Nazione #
US - Stati Uniti d'America 4.399
CN - Cina 1.455
SG - Singapore 1.404
IT - Italia 1.010
DE - Germania 710
GB - Regno Unito 543
VN - Vietnam 481
SE - Svezia 413
HK - Hong Kong 299
KR - Corea 257
BR - Brasile 224
IN - India 213
RU - Federazione Russa 178
NL - Olanda 143
IE - Irlanda 133
FR - Francia 126
CI - Costa d'Avorio 86
BG - Bulgaria 75
FI - Finlandia 65
CH - Svizzera 52
ZA - Sudafrica 49
JP - Giappone 48
ES - Italia 40
UA - Ucraina 39
AR - Argentina 38
AT - Austria 38
EE - Estonia 36
BE - Belgio 35
JO - Giordania 35
TG - Togo 35
ID - Indonesia 32
CA - Canada 30
NG - Nigeria 27
MX - Messico 19
SC - Seychelles 15
EC - Ecuador 13
AU - Australia 12
BD - Bangladesh 11
CO - Colombia 11
PL - Polonia 10
RO - Romania 10
PH - Filippine 9
LT - Lituania 8
IQ - Iraq 7
PK - Pakistan 7
TR - Turchia 7
GR - Grecia 6
IR - Iran 6
MY - Malesia 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
CZ - Repubblica Ceca 5
HR - Croazia 5
PT - Portogallo 5
SA - Arabia Saudita 5
TH - Thailandia 5
UY - Uruguay 5
CY - Cipro 4
KE - Kenya 4
PE - Perù 4
TN - Tunisia 4
AL - Albania 3
AZ - Azerbaigian 3
BB - Barbados 3
KZ - Kazakistan 3
MA - Marocco 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BZ - Belize 2
DK - Danimarca 2
DZ - Algeria 2
IL - Israele 2
LB - Libano 2
LY - Libia 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
SM - San Marino 2
TW - Taiwan 2
TZ - Tanzania 2
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GH - Ghana 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
MR - Mauritania 1
NE - Niger 1
NO - Norvegia 1
Totale 13.030
Città #
Singapore 969
Ashburn 600
Hefei 556
Southend 456
Fairfield 435
Frankfurt am Main 365
Chandler 321
Hong Kong 297
Seoul 248
Bologna 220
Wilmington 200
Santa Clara 198
Woodbridge 198
Ann Arbor 196
Seattle 166
Houston 164
Beijing 162
Cambridge 147
Dublin 132
Princeton 129
Ho Chi Minh City 127
Boardman 109
New York 108
Dong Ket 101
Milan 88
Abidjan 86
Hanoi 76
Sofia 71
Los Angeles 67
Dallas 61
Bengaluru 54
Rome 52
Nanjing 44
Westminster 43
Helsinki 41
Tokyo 40
Bern 39
Berlin 38
Chicago 38
Padova 37
Buffalo 36
Munich 36
Redondo Beach 36
Saint Petersburg 36
Amman 35
Lomé 35
Turin 30
Brussels 29
Jinan 29
San Diego 29
São Paulo 29
Bremen 28
Redmond 28
Falls Church 27
Vienna 26
Nuremberg 25
Amsterdam 24
Jakarta 23
Abeokuta 21
London 21
Shanghai 21
Shenyang 20
Redwood City 18
Florence 17
Guangzhou 17
Hebei 17
Nanchang 17
Parma 17
Modena 16
Tongling 16
Washington 16
Changsha 15
Dearborn 15
Zhengzhou 15
Des Moines 14
Yubileyny 14
Lappeenranta 13
Toronto 13
Falkenstein 12
Naples 12
San Francisco 12
Verona 12
Brescia 11
Brooklyn 11
Olalla 11
Rio de Janeiro 11
Tampa 11
Turku 11
Denver 10
Leganés 10
Mexico City 10
Moscow 10
Mumbai 10
Bogotá 9
Bühl 9
Ningbo 9
Reggio Emilia 9
Thái Nguyên 9
Tianjin 9
Venice 9
Totale 8.580
Nome #
[Prospective multicentre survey on clinical features and management approach to community-acquired pneumonia in emergency departments in Italy: focus on hospital admitted cases] 532
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 288
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 227
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia 210
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 204
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 204
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 201
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 196
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 188
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 188
Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department 187
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 184
Pharmacokinetic and pharmacodynamic considerations for optimizing antimicrobial therapy used to treat bone and joint infections: an evidence-based algorithmic approach 184
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 182
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 174
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections 172
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 166
Superficial swab versus deep-tissue biopsy for the microbiological diagnosis of local infection in advanced-stage pressure ulcers of spinal-cord-injured patients: a prospective study 164
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 163
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 162
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 161
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 160
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 152
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 152
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 146
Clinical impact of reninangiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for coronavirus disease 2019 145
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort 143
Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients. 143
Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy 143
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients 143
The burden of colonization and infection by carbapenemase-producing Enterobacteriaceae in the neuro-rehabilitation setting: A prospective six-year experience 142
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 141
Population pharmacokinetics and Monte Carlo simulation for dosage optimization of fosfomycin in the treatment of osteoarticular infections in patients without renal dysfunction 140
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 139
Oral Versus Standard Antimicrobial Treatment for Pyogenic Native Vertebral Osteomyelitis: A Single-Center, Retrospective, Propensity Score-Balanced Analysis 138
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 136
Clinical experience with dalbavancin for the treatment of deep sternal wound infection 136
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 135
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy 135
Use of Daptomycin in Critically Ill Children with Bloodstream Infections and Complicated Skin and Soft-tissue Infections 134
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 134
Population Pharmacokinetics and Pharmacodynamics of Dalbavancin and C-Reactive Protein in Patients with Staphylococcal Osteoarticular Infections 130
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors 130
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 130
Multidisciplinary treatment protocol for ischiatic, sacral, trochanteric or other pressure injuries in people with spinal cord injury: a retrospective cohort study 129
A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing Klebsiella pneumoniae infections and on ceftazidime/avibactam resistance development 129
Could a Reduced Dose of 8 g of Continuous Infusion Fosfomycin Be Considered as Effective as and Safer than a Standard 16 g Dose When Combined with High-Dose Daptomycin in the Treatment of Staphylococcal osteoarticular Infections? 128
Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for treating subacute and/or chronic staphylococcal infections 127
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 124
Treatment of MDR-Gram negative infections in the 21st century: a never ending threat for clinicians 124
Incidence, associated disease burden and healthcare utilization due to Staphylococcus aureus prosthetic joint infection in European hospitals: the COMBACTE-NET ARTHR-IS multi-centre study 121
Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naive patients. 121
Silver-Coated Distal Femur Megaprosthesis in Chronic Infections with Severe Bone Loss: A Multicentre Case Series 119
In the search for appropriateness in the cure of vaginitis: a model of anti-fungal stewardship? 115
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 115
Opportunistic infections in end stage liver disease 114
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 114
Population pharmacokinetics of dalbavancin and dosing consideration for optimal treatment of adult patients with staphylococcal osteoarticular infections 114
Combined Orthoplastic Approach in Fracture-Related Infections of the Distal Tibia 113
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 113
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort 112
Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients 111
Prevention of infections in nursing homes: Antibiotic prophylaxis versus infection control and antimicrobial stewardship measures 110
The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis 110
Multiple Flaps for Trochanteric Pressure Sore Reconstruction: A Case Series 109
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 109
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study 109
Bone and Joint Infections: The Role of Imaging in Tailoring Diagnosis to Improve Patients' Care 109
Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug Monitoring 107
Reply: Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 105
Epidemiology of Fungal Periprosthetic Joint Infection: A Systematic Review of the Literature 103
Individualizing duration of antibiotic therapy in community-acquired pneumonia 99
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 98
Usefulness of a hub and spoke TDM-guided expert clinical pharmacological advice program of dalbavancin for optimizing very long-term curative or suppressive treatment of chronic staphylococcal infections 96
A local outbreak as mirror-like scenario for COVID-19 worldwide progression. Clinical presentation to the Emergency Department during one of the first sub-regional outbreak in Italy A lesson to learn 96
Effective Containment of a COVID-19 Subregional Outbreak in Italy through Strict Quarantine and Rearrangement of Local Health Care Services 95
"MRI, culture of swab specimen and two stage surgery in spinal cord injury patients with pressure sores" 93
Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study 92
Treatment duration for central line-associated infection caused by Enterococcus spp.: a retrospective evaluation of a multicenter cohort 92
Rates and Predictors of Treatment Failure in Staphylococcus aureus Prosthetic Joint Infections According to Different Management Strategies: A Multinational Cohort Study-The ARTHR-IS Study Group 91
null 91
An Improvement in the Antimicrobial Resistance Patterns of Urinary Isolates in the Out-Of-Hospital Setting following Decreased Community Use of Antibiotics during the COVID-19 Pandemic 90
null 90
GPT-based chatbot tools are still unreliable in the management of prosthetic joint infections 87
Usefulness of therapeutic drug monitoring in estimating the duration of dalbavancin optimal target attainment in staphylococcal osteoarticular infections: a proof-of-concept 87
Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda 86
Healthcare-associated infections and antimicrobial resistance in severe acquired brain injury: a retrospective multicenter study 85
Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study 77
The Need for Multidisciplinarity in Modern Medicine: An Insight into Orthopaedic Infections 77
null 77
null 76
A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis 75
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: An observational multicenter study 72
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients 70
Obesity Is One of the Strongest Risk Factor for Respiratory Failure and Death in COVID-19 Patients: A Retrospective Multicentric Cohort Study 69
Synchronous Periprosthetic Joint Infections: A Scoping Review of the Literature 67
Reply to Baklouti et al., "Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model?" 66
Osteomyelitis of the pelvic bones in patients with spinal cord injury: Is magnetic resonance useful for preoperative diagnosis? 62
The efficacy of suppressive antibiotic treatment in patients managed non-operatively for periprosthetic joint infection and a draining sinus 62
null 56
Totale 13.052
Categoria #
all - tutte 38.512
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.512


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021601 0 0 0 0 0 46 12 63 92 77 55 256
2021/20221.393 61 56 65 144 121 77 80 100 77 157 257 198
2022/20231.603 123 177 87 219 147 118 60 113 294 68 112 85
2023/2024897 70 90 54 105 76 194 63 58 33 72 36 46
2024/20252.709 112 247 214 214 313 149 196 93 58 244 263 606
2025/20264.088 718 857 649 567 639 658 0 0 0 0 0 0
Totale 13.371